USFDA issues 1 minor procedural observation to JB Chem’s Panoli unit

USFDA issues 1 minor procedural observation to JB Chem’s Panoli unit

by admin- Monday, February 10th, 2020 04:20:27 PM

JB Chemical & Pharmaceutical has introduced that Company’s USFDA permitted stable oral dosage forms formulations production facility at Panoli, Gujarat has efficiently handed periodical inspection by means of US FDA with one minor procedural commentary. This statement do no longer effect continuity of Company’s commercial enterprise and the Company might preserve its manufacturing sports in cGMP compliant manner. The Company proposes to cope with this remark in the subsequent 15 days. The said inspection become carried-out from February 03, 2020 to February 07, 2020.

This is the tenth consecutive a success inspection for this facility.

News Updates